US Stock MarketDetailed Quotes

WINT Windtree Therapeutics

Watchlist
  • 8.1100
  • -0.8300-9.28%
Close Aug 30 16:00 ET
  • 8.1200
  • +0.0100+0.12%
Post 20:02 ET
4.80MMarket Cap-426P/E (TTM)

Windtree Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
33.49%-2.33M
-16.99%-2.95M
30.92%-13.44M
-5.53%-3.57M
5.98%-3.85M
33.49%-3.5M
62.49%-2.52M
17.80%-19.45M
31.47%-3.38M
22.38%-4.1M
Net income from continuing operations
-82.15%-12.02M
348.58%10.22M
48.25%-20.29M
46.82%-5.15M
-9.10%-4.43M
61.92%-6.6M
49.42%-4.11M
42.03%-39.21M
25.86%-9.69M
50.61%-4.06M
Operating gains losses
331.13%245K
-70,238.10%-14.73M
101.30%9K
11.69%258K
64.04%-164K
53.91%-106K
108.90%21K
-274.49%-691K
255.38%231K
-1,570.97%-456K
Depreciation and amortization
-2.97%229K
-8.70%21K
-84.62%82K
-8.33%22K
-1,047.62%-199K
972.73%236K
-95.06%23K
177.60%533K
-53.85%24K
-55.32%21K
Deferred tax
----
----
--0
----
----
----
----
86.31%-1.37M
----
----
Other non cash items
--7.38M
-12.93%101K
-22.54%409K
-9.91%100K
----
----
-33.33%116K
-54.91%528K
-35.47%111K
-34.91%110K
Change In working capital
1,174.63%1.71M
79.49%1.19M
213.56%2.02M
208.29%901K
134.93%320K
150.19%134K
178.57%663K
-2,963.79%-1.78M
-231.02%-832K
-186.74%-916K
-Change in prepaid assets
724.42%537K
23.85%270K
-14.22%923K
23.39%480K
62.83%311K
-133.46%-86K
-8.79%218K
-21.17%1.08M
-43.05%389K
-62.03%191K
-Change in payables and accrued expense
295.69%1.29M
111.19%1.21M
127.43%626K
64.94%-386K
111.69%115K
185.75%325K
214.29%572K
-160.80%-2.28M
-3,340.63%-1.1M
-234.24%-984K
-Change in other current liabilities
-9.52%-115K
-126.77%-288K
182.14%469K
772.50%807K
13.82%-106K
27.59%-105K
30.60%-127K
-4.20%-571K
-650.00%-120K
31.67%-123K
Cash from discontinued investing activities
Operating cash flow
33.49%-2.33M
-16.99%-2.95M
30.92%-13.44M
-5.53%-3.57M
5.98%-3.85M
33.49%-3.5M
62.49%-2.52M
17.80%-19.45M
31.47%-3.38M
22.38%-4.1M
Investing cash flow
Cash flow from continuing investing activities
-107.61%-15K
0
-15K
170.61%197K
0
0
Net PPE purchase and sale
----
----
-107.61%-15K
--0
---15K
----
----
170.61%197K
--0
--0
Cash from discontinued investing activities
Investing cash flow
----
----
-107.61%-15K
--0
---15K
----
----
170.61%197K
--0
--0
Financing cash flow
Cash flow from continuing financing activities
-85.13%1.59M
74.96%1.03M
276.58%11.6M
-53.32%521K
-120.14%-233K
1,097.32%10.72M
764.04%591K
-89.51%3.08M
-61.68%1.12M
2,992.50%1.16M
Net issuance payments of debt
2,230.77%1.66M
7.54%-233K
32.11%-797K
37.93%-234K
38.36%-233K
37.60%-78K
14.29%-252K
69.68%-1.17M
14.51%-377K
14.09%-378K
Net common stock issuance
--0
--1.37M
171.55%11.55M
-49.43%755K
--0
958.24%10.79M
--0
-86.81%4.25M
-52.65%1.49M
--1.54M
Proceeds from stock option exercised by employees
--0
--0
--843K
--0
--0
--0
--843K
--0
--0
--0
Net other financing activities
---68K
---100K
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-85.13%1.59M
74.96%1.03M
276.58%11.6M
-53.32%521K
-120.14%-233K
1,097.32%10.72M
764.04%591K
-89.51%3.08M
-61.68%1.12M
2,992.50%1.16M
Net cash flow
Beginning cash position
-41.88%2.56M
-29.36%4.47M
-71.89%6.33M
-12.51%7.52M
0.74%11.62M
-71.98%4.4M
-71.89%6.33M
31.71%22.5M
-65.22%8.59M
-61.71%11.53M
Current changes in cash
-110.31%-744K
0.78%-1.91M
88.52%-1.86M
-34.54%-3.05M
-39.43%-4.1M
273.41%7.22M
71.68%-1.93M
-398.56%-16.18M
-3.24%-2.26M
45.76%-2.94M
End cash Position
-84.40%1.81M
-41.88%2.56M
-29.36%4.47M
-29.36%4.47M
-12.51%7.52M
0.74%11.62M
-71.98%4.4M
-71.89%6.33M
-71.89%6.33M
-65.22%8.59M
Free cash flow
33.14%-2.34M
-16.99%-2.95M
30.89%-13.45M
-5.53%-3.57M
5.61%-3.87M
33.62%-3.5M
62.50%-2.52M
18.70%-19.47M
33.79%-3.38M
23.87%-4.1M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 33.49%-2.33M-16.99%-2.95M30.92%-13.44M-5.53%-3.57M5.98%-3.85M33.49%-3.5M62.49%-2.52M17.80%-19.45M31.47%-3.38M22.38%-4.1M
Net income from continuing operations -82.15%-12.02M348.58%10.22M48.25%-20.29M46.82%-5.15M-9.10%-4.43M61.92%-6.6M49.42%-4.11M42.03%-39.21M25.86%-9.69M50.61%-4.06M
Operating gains losses 331.13%245K-70,238.10%-14.73M101.30%9K11.69%258K64.04%-164K53.91%-106K108.90%21K-274.49%-691K255.38%231K-1,570.97%-456K
Depreciation and amortization -2.97%229K-8.70%21K-84.62%82K-8.33%22K-1,047.62%-199K972.73%236K-95.06%23K177.60%533K-53.85%24K-55.32%21K
Deferred tax ----------0----------------86.31%-1.37M--------
Other non cash items --7.38M-12.93%101K-22.54%409K-9.91%100K---------33.33%116K-54.91%528K-35.47%111K-34.91%110K
Change In working capital 1,174.63%1.71M79.49%1.19M213.56%2.02M208.29%901K134.93%320K150.19%134K178.57%663K-2,963.79%-1.78M-231.02%-832K-186.74%-916K
-Change in prepaid assets 724.42%537K23.85%270K-14.22%923K23.39%480K62.83%311K-133.46%-86K-8.79%218K-21.17%1.08M-43.05%389K-62.03%191K
-Change in payables and accrued expense 295.69%1.29M111.19%1.21M127.43%626K64.94%-386K111.69%115K185.75%325K214.29%572K-160.80%-2.28M-3,340.63%-1.1M-234.24%-984K
-Change in other current liabilities -9.52%-115K-126.77%-288K182.14%469K772.50%807K13.82%-106K27.59%-105K30.60%-127K-4.20%-571K-650.00%-120K31.67%-123K
Cash from discontinued investing activities
Operating cash flow 33.49%-2.33M-16.99%-2.95M30.92%-13.44M-5.53%-3.57M5.98%-3.85M33.49%-3.5M62.49%-2.52M17.80%-19.45M31.47%-3.38M22.38%-4.1M
Investing cash flow
Cash flow from continuing investing activities -107.61%-15K0-15K170.61%197K00
Net PPE purchase and sale ---------107.61%-15K--0---15K--------170.61%197K--0--0
Cash from discontinued investing activities
Investing cash flow ---------107.61%-15K--0---15K--------170.61%197K--0--0
Financing cash flow
Cash flow from continuing financing activities -85.13%1.59M74.96%1.03M276.58%11.6M-53.32%521K-120.14%-233K1,097.32%10.72M764.04%591K-89.51%3.08M-61.68%1.12M2,992.50%1.16M
Net issuance payments of debt 2,230.77%1.66M7.54%-233K32.11%-797K37.93%-234K38.36%-233K37.60%-78K14.29%-252K69.68%-1.17M14.51%-377K14.09%-378K
Net common stock issuance --0--1.37M171.55%11.55M-49.43%755K--0958.24%10.79M--0-86.81%4.25M-52.65%1.49M--1.54M
Proceeds from stock option exercised by employees --0--0--843K--0--0--0--843K--0--0--0
Net other financing activities ---68K---100K--------------------------------
Cash from discontinued financing activities
Financing cash flow -85.13%1.59M74.96%1.03M276.58%11.6M-53.32%521K-120.14%-233K1,097.32%10.72M764.04%591K-89.51%3.08M-61.68%1.12M2,992.50%1.16M
Net cash flow
Beginning cash position -41.88%2.56M-29.36%4.47M-71.89%6.33M-12.51%7.52M0.74%11.62M-71.98%4.4M-71.89%6.33M31.71%22.5M-65.22%8.59M-61.71%11.53M
Current changes in cash -110.31%-744K0.78%-1.91M88.52%-1.86M-34.54%-3.05M-39.43%-4.1M273.41%7.22M71.68%-1.93M-398.56%-16.18M-3.24%-2.26M45.76%-2.94M
End cash Position -84.40%1.81M-41.88%2.56M-29.36%4.47M-29.36%4.47M-12.51%7.52M0.74%11.62M-71.98%4.4M-71.89%6.33M-71.89%6.33M-65.22%8.59M
Free cash flow 33.14%-2.34M-16.99%-2.95M30.89%-13.45M-5.53%-3.57M5.61%-3.87M33.62%-3.5M62.50%-2.52M18.70%-19.47M33.79%-3.38M23.87%-4.1M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg